Palliative sedation – revised recommendations

Article

BEAUVERD, Michel | MAZZOLI, Marta | PRALONG, Josiane | TOMCZYK, Martyna | EYCHMÜLLER, Steffen | GAERTNER, Jan

Palliative sedation is defined as the monitored use of medications intended to induce a state of decreased or absent awareness (unconsciousness) to relieve the burden of otherwise intractable suffering in a manner ethically acceptable to the patient, their family, and healthcare providers. In Switzerland, the prevalence of continuous deep sedation until death increased from 4.7% in 2001 to 17.5% of all deceased in 2013, depending on the research method used and on regional variations. Yet, these numbers may be overestimated due to a lack of understanding of the term “continuous deep sedation” by for example respondents of the questionnaire-based study. Inadequately trained and inexperienced healthcare professionals may incorrectly or inappropriately perform palliative sedation due to uncertainties regarding its definitions and practice. Therefore, the expert members of the Bigorio group and the authors of this manuscript believe that national recommendations should be published and made available to healthcare professionals to provide practical, terminological, and ethical guidance. The Bigorio group is the working group of the Swiss Palliative Care Society whose task is to publish clinical recommendations at a national level in Switzerland. These recommendations aim to provide guidance on the most critical questions and issues related to palliative sedation. The Swiss Society of Palliative Care (palliative.ch) mandated a writing board comprising four clinical experts (three physicians and one ethicist) and two national academic experts to revise the 2005 Bigorio guidelines. A first draft was created based on a narrative literature review, which was internally reviewed by five academic institutions (Lausanne, Geneva, Bern, Zürich, and Basel) and the heads of all working groups of the Swiss Society of Palliative Care before finalising the guidelines. The following themes are discussed regarding palliative sedation: (a) definitions and clinical aspects, (b) the decision-making process, (c) communication with patients and families, (d) patient monitoring, (e) pharmacological approaches, and (f) ethical and controversial issues. Palliative sedation must be practised with clinical and ethical accuracy and competence to avoid harm and ethically questionable use. Specialist palliative care teams should be consulted before initiating palliative sedation to avoid overlooking other potential treatment options for the patient’s symptoms and suffering.

https://smw.ch/index.php/smw/article/view/3590

Voir la revue «Swiss medical weekly, 154»

Autres numéros de la revue «Swiss medical weekly»

Consulter en ligne

Suggestions

Du même auteur

Palliative sedation – revised recommendations

Article indépendant | BEAUVERD, Michel | Swiss medical weekly | n°2 | vol.154

Palliative sedation is defined as the monitored use of medications intended to induce a state of decreased or absent awareness (unconsciousness) to relieve the burden of otherwise intractable suffering in a manner ethically accept...

Giving and receiving thanks : a mixed methods...

Article indépendant | BERNARD, Mathieu | BMC palliative care | n°1 | vol.22

Background: Psychological research examining the nature and workings of gratitude has burgeoned over the past two decades. However, few studies have considered gratitude in the palliative care context. Based on an exploratory stud...

Giving and receiving thanks : a mixed methods...

Article indépendant | BERNARD, Mathieu | BMC palliative care | n°1 | vol.22

Background: Psychological research examining the nature and workings of gratitude has burgeoned over the past two decades. However, few studies have considered gratitude in the palliative care context. Based on an exploratory stud...

De la même série

Palliative sedation – revised recommend...

Article | BEAUVERD, Michel | Swiss medical weekly | n°2 | vol.154

Palliative sedation is defined as the monitored use of medications intended to induce a state of decreased or absent awareness (unconsciousness) to relieve the burden of otherwise intractable suffering in a manner ethically accept...

An economic evaluation of an early palliative...

Article | MAESSEN, Maud | Swiss medical weekly | vol.154

BACKGROUND: Early integration of palliative care into oncology care has shown positive effects on patient symptoms and quality of life. It may also reduce health care costs. However given the heterogeneity of settings and interven...

Early advance care planning in amyotrophic la...

Article | SUKOCKIENE, Eglé | Swiss medical weekly | vol.151

INTRODUCTION: Although recommended, the implementation of early advance care planning is suboptimal in amyotrophic lateral sclerosis (ALS) patients. Barriers to advance care planning include healthcare professionals' and patient' ...

Awareness, approval and completion of advance...

Article | VILPERT, Sarah | Swiss medical weekly | vol.148

BACKGROUND: Advance directives enable people to describe their preferences for medical treatment (living will) and/or to appoint a healthcare proxy who may decide on their behalf should they lose decision-making capacity. Advance ...

Planning ahead with dementia : what role can ...

Article | BOSISIO, Francesca | Swiss medical weekly | vol.148

Advance directives emerged in the 1960s with the goal of empowering people to exert control over their future medical decisions. However, it has become apparent, over recent years, that advance directives do not sufficiently captu...

Chargement des enrichissements...